Data-driven step doses for drug provocation tests to non-steroidal anti-inflammatory drugs.
Hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) are of great concern because they are frequently encountered in daily clinical practice. Drug provocation tests (DPT) are particularly needed for NSAIDs. The aim of this retrospective study was to detect eliciting dose thresholds during NSAIDs DPT in order to suggest optimal step doses, using the survival analysis method. Our secondary objective was to describe subgroups at higher risk during DPT and evaluate the safety of our 30 min incremental 1 day protocol. The study comprised all the patients attended the Allergy of the University Hospital of Montpellier (France), between 1997 and 2017 for a suspicion of drug hypersensitivity reaction to NSAIDs. Throughout the study period 311 positive DPT were analyzed (accounting for 285 hypersensitive patients). We identified eliciting thresholds (dose and time) and we suggest the following steps for future DPT. for the rapid absorption group (Acetylsalicylic acid, ibuprofen, ketoprofen, tiaprofenic acid), every 30 min: 20%-30%-50% of daily therapeutic dose, for the moderate absorption group, every 30 min: for diclofenac 5%-15%-30%-50% and for celecoxib, 20%-80%. For the slow absorption group, piroxicam, 25%-75% separated by a 3h interval. A surveillance period of 3h after the last dose is mandatory for patients. DPT protocols for NSAID are empirical, driven by the knowledge on patterns of DHR, cross-reactivity between NSAID and pharmacological effects of these all drugs. This is the second experience in improving DPT protocols, after BL (B-Lactam) antibiotics.